Hiroshi Yamazaki mostly deals with Biochemistry, Cytochrome P450, Microsome, Enzyme and CYP3A4. His work in Biochemistry is not limited to one particular discipline; it also encompasses Stereochemistry. His biological study spans a wide range of topics, including Metabolite, Cytochrome and Drug metabolism.
His Microsome research is multidisciplinary, incorporating elements of Cytochrome P-450 CYP3A, Isozyme, Internal medicine and Endocrinology. As part of the same scientific family, Hiroshi Yamazaki usually focuses on Enzyme, concentrating on Peptide sequence and intersecting with Molecular biology. His CYP3A4 study frequently links to other fields, such as Pharmacology.
His primary areas of study are Cytochrome P450, Biochemistry, Pharmacology, Microsome and Enzyme. His work carried out in the field of Cytochrome P450 brings together such families of science as Molecular biology, Drug metabolism and Hydroxylation. His Molecular biology research is multidisciplinary, relying on both Complementary DNA and Genetics.
His Biochemistry study frequently involves adjacent topics like Stereochemistry. His research integrates issues of Metabolite and In vivo in his study of Pharmacology. His Microsome study combines topics from a wide range of disciplines, such as Endocrinology, Monooxygenase, Cytochrome P-450 CYP3A, Internal medicine and Isozyme.
Hiroshi Yamazaki mainly investigates Pharmacology, Pharmacokinetics, Enzyme, Drug metabolism and Cytochrome P450. The concepts of his Pharmacology study are interwoven with issues in Metabolite, Thalidomide, Toxicity and In vivo. His Pharmacokinetics research includes elements of Oral administration, Chromatography and Glucuronide.
His research in Enzyme tackles topics such as Molecular biology which are related to areas like Amino acid. His Drug metabolism study also includes
Hiroshi Yamazaki focuses on Pharmacology, Pharmacokinetics, Drug metabolism, Cytochrome P450 and Marmoset. His studies in Pharmacology integrate themes in fields like In vitro, Thalidomide, Toxicity and In vivo. While the research belongs to areas of In vivo, Hiroshi Yamazaki spends his time largely on the problem of Microsome, intersecting his research to questions surrounding Hydroxylation.
His Pharmacokinetics research incorporates elements of Oral administration, Metabolite, CYP2C19 and Warfarin. His Drug metabolism research includes themes of CYP3A4, Nonsynonymous substitution and Gene, Gene isoform. His Cytochrome P450 study is concerned with the larger field of Biochemistry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
T Shimada;H Yamazaki;M Mimura;Y Inui.
Journal of Pharmacology and Experimental Therapeutics (1994)
Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1
Tsutomu Shimada;Carrie L. Hayes;Hiroshi Yamazaki;Shantu Amin.
Cancer Research (1996)
Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes
Hiroshi Yamazaki;Yukiharu Inui;Chul-Ho Yun;F.Peter Guengerich.
Carcinogenesis (1992)
Progesterone and Testosterone Hydroxylation by Cytochromes P450 2C19, 2C9, and 3A4 in Human Liver Microsomes
Hiroshi Yamazaki;Tsutomu Shimada.
Archives of Biochemistry and Biophysics (1997)
Activation and detoxication of aflatoxin B1
F P Guengerich;W W Johnson;T Shimada;Y F Ueng.
Mutation Research (1998)
Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens.
T. Shimada;Chul-Ho Yun;H. Yamazaki;J.-C. Gautier.
Molecular Pharmacology (1992)
Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs.
T. Shimada;H. Yamazaki;M. Mimura;N. Wakamiya.
Drug Metabolism and Disposition (1996)
Regio- and stereocontrolled dimerization of tert-butylacetylene to (Z)-1,4-di-tert-butylbutatriene by ruthenium catalysis. Reaction mechanism involving alkynyl-vinylidene coupling and rearrangement of the metal-bound C4 unit
Yasuo Wakatsuki;Hiroshi Yamazaki;Nami Kumegawa;Toshiaki Satoh.
Journal of the American Chemical Society (1991)
Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes.
Hiroshi Yamazaki;Kiyoshi Inoue;Masafumi Hashimoto;Tsutomu Shimada.
Archives of Toxicology (1999)
Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 reductase system and studies with apo-cytochrome b5.
Hiroshi Yamazaki;William W. Johnson;Yune-Fang Ueng;Tsutomu Shimada.
Journal of Biological Chemistry (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Vanderbilt University
Vanderbilt University
Bridgestone (Japan)
Hokkaido University
Kanazawa University
Nagoya University
Nagoya Institute of Technology
Tokyo Institute of Technology
Osaka City University
Tohoku University
Technical University of Berlin
Vanderbilt University
University of Ljubljana
ParkerVision
Carnegie Mellon University
Chinese Academy of Sciences
Chinese Academy of Sciences
Harvard University
University of Rennes
Vanderbilt University Medical Center
Hebrew University of Jerusalem
The University of Texas at Austin
Boston Medical Center
Karolinska Institute
Charité - University Medicine Berlin
Murdoch University